Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Pharma
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
At the Senate committee hearing on Novo Nordisk's Ozempic and Wegovy prices, insurance-related debate took up much of the conversation.
Zoey Becker
Sep 24, 2024 5:03pm
Lawmakers urge government to allow generics to Novo GLP-1s
Sep 23, 2024 5:28pm
Novo Nordisk rekindles heart failure hopes for semaglutide
Aug 30, 2024 11:48am
Novo Nordisk plans new $220M raw ingredients plant
Aug 16, 2024 11:20am
Novo breached marketing rules with CEO’s Wegovy interview: PMCPA
Aug 8, 2024 12:30pm
Novo re-ups supplies on most doses of obesity med Wegovy
Aug 7, 2024 12:49pm
65e7.jpg?VersionId=HcEbagt.YOtkQVRw3roQO3uc2EWN6NJf)
